14485

    530199

    THEMISMED

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    THEMIS MEDICARE LTD. Share Price Today

    THEMIS MEDICARE LTD. is currently trading at ₹116.33, down by ₹0.62 from the previous close. The stock touched an intraday high of ₹117.62 and a low of ₹115.00 during the latest trading session. Over the past one year, THEMIS MEDICARE LTD. has delivered a loss of 5.59%, while the stock has gained 13.39% in the last one month.

    THEMIS MEDICARE LTD. performance

    Today’s low Today’s high
    ₹ 115.00 ₹ 117.62
    ₹ 116.17
    52 week low 52 week high
    ₹ 64.95 ₹ 148.00
    ₹ 116.17
    Open Price ₹ 116.55
    Prev. Close ₹ 116.96
    Volume (Shares) 36140.00
    Total traded value ₹ 41.98
    Upper Circuit ₹ 140.35
    Lower Circuit ₹ 93.57
    info

    Investment Returns

    Over 1 Month 13.39% Over 3 Months 39.92% Over 6 Months 22.98% Over 1 Year -5.59%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    THEMIS MEDICARE LTD. fundamentals


    • Market cap (Cr) 1,069.90
    • P/E Ratio (TTM) -75.97
    • Beta 1.46
    • Book Value / share 29.09
    • Return on equity 8.62%
    • EPS (TTM) 0.00
    • Dividend yield 0.43%
    • Net profit/quarter (Cr) 1.97
    info icon alternate text
    • Market cap (Cr) 1,072.00
    • P/E Ratio (TTM) -75.97
    • Beta 1.29
    • Book Value / share 29.09
    • Return on equity 8.62%
    • EPS (TTM) 0.00
    • Dividend yield 0.43%
    • Net profit/quarter (Cr) 1.97
    info icon alternate text

    THEMIS MEDICARE LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 76.53
    Operating Expense 78.06
    Net Profit 1.97
    Net Profit Margin (%) 2.57
    Earnings Per Share (EPS) 0.21
    EBITDA 7.43
    Effective Tax Rate (%) 7.94
    Particulars DEC 2025 (Values in Cr)
    Revenue 90.13
    Operating Expense 85.68
    Net Profit 4.58
    Net Profit Margin (%) 5.08
    Earnings Per Share (EPS) 0.50
    EBITDA 10.21
    Effective Tax Rate (%) 5.95
    Particulars SEP 2025 (Values in Cr)
    Revenue 77.99
    Operating Expense 86.42
    Net Profit -5.36
    Net Profit Margin (%) -6.87
    Earnings Per Share (EPS) -0.58
    EBITDA 0.13
    Effective Tax Rate (%) -3.08
    Particulars JUN 2025 (Values in Cr)
    Revenue 97.58
    Operating Expense 112.67
    Net Profit -15.37
    Net Profit Margin (%) -15.75
    Earnings Per Share (EPS) -1.67
    EBITDA -10.20
    Effective Tax Rate (%) -1.05
    Particulars MAR 2025 (Values in Cr)
    Revenue 71.70
    Operating Expense 82.46
    Net Profit -7.74
    Net Profit Margin (%) -10.79
    Earnings Per Share (EPS) -0.84
    EBITDA -4.23
    Effective Tax Rate (%) 15.85
    Particulars MAR 2026 (Values in Cr)
    Revenue 342.24
    Operating Expense 362.84
    Net Profit -14.19
    Net Profit Margin (%) -4.14
    Earnings Per Share (EPS) -1.54
    EBITDA 7.60
    Effective Tax Rate (%) -5.82
    Particulars MAR 2025 (Values in Cr)
    Revenue 405.51
    Operating Expense 376.42
    Net Profit 23.92
    Net Profit Margin (%) 5.89
    Earnings Per Share (EPS) 2.60
    EBITDA 53.73
    Effective Tax Rate (%) 29.14
    Particulars MAR 2024 (Values in Cr)
    Revenue 381.76
    Operating Expense 351.85
    Net Profit 24.75
    Net Profit Margin (%) 6.48
    Earnings Per Share (EPS) 2.69
    EBITDA 56.30
    Effective Tax Rate (%) 28.61
    Particulars MAR 2023 (Values in Cr)
    Revenue 354.32
    Operating Expense 306.92
    Net Profit 43.29
    Net Profit Margin (%) 12.21
    Earnings Per Share (EPS) 47.05
    EBITDA 78.96
    Effective Tax Rate (%) 26.49
    Particulars MAR 2022 (Values in Cr)
    Revenue 394.61
    Operating Expense 317.21
    Net Profit 61.56
    Net Profit Margin (%) 15.60
    Earnings Per Share (EPS) 66.91
    EBITDA 102.19
    Effective Tax Rate (%) 26.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 40.16
    ROE % 8.36
    ROCE % 11.09
    Total Debt to Total Equity 0.25
    EBITDA Margin 14.71
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 37.41
    ROE % 13.39
    ROCE % 14.99
    Total Debt to Total Equity 0.29
    EBITDA Margin 19.66
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 332.15
    ROE % 20.36
    ROCE % 22.45
    Total Debt to Total Equity 0.31
    EBITDA Margin 26.13
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 275.34
    ROE % 33.33
    ROCE % 34.44
    Total Debt to Total Equity 0.38
    EBITDA Margin 28.77
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 200.18
    ROE % 21.51
    ROCE % 20.82
    Total Debt to Total Equity 0.56
    EBITDA Margin 27.13
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 31.22
    ROE % 8.62
    ROCE % 11.88
    Total Debt to Total Equity 0.32
    EBITDA Margin 13.25
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 29.11
    ROE % 9.59
    ROCE % 12.48
    Total Debt to Total Equity 0.36
    EBITDA Margin 14.74
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 269.54
    ROE % 18.93
    ROCE % 21.75
    Total Debt to Total Equity 0.38
    EBITDA Margin 22.28
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 227.50
    ROE % 34.15
    ROCE % 35.15
    Total Debt to Total Equity 0.46
    EBITDA Margin 25.90
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 164.59
    ROE % 19.32
    ROCE % 19.43
    Total Debt to Total Equity 0.68
    EBITDA Margin 23.19
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.83
    Total Assets 588.03
    Total Liabilities 588.03
    Total Equity 402.59
    Share Outstanding 9
    Price to Book Ratio 4.70
    Return on Assets (%) 5.07
    Return on Capital (%) 6.14
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 19.29
    Total Assets 566.41
    Total Liabilities 566.41
    Total Equity 377.66
    Share Outstanding 9
    Price to Book Ratio 7.52
    Return on Assets (%) 7.68
    Return on Capital (%) 9.19
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 18.88
    Total Assets 513.95
    Total Liabilities 513.95
    Total Equity 339.44
    Share Outstanding 0
    Price to Book Ratio 4.33
    Return on Assets (%) 11.07
    Return on Capital (%) 13.19
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 26.49
    Total Assets 427.78
    Total Liabilities 427.78
    Total Equity 287.48
    Share Outstanding 0
    Price to Book Ratio 4.10
    Return on Assets (%) 17.03
    Return on Capital (%) 19.91
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 24.63
    Total Assets 371.14
    Total Liabilities 371.14
    Total Equity 218.50
    Share Outstanding 0
    Price to Book Ratio 1.70
    Return on Assets (%) 9.61
    Return on Capital (%) 11.76
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.74
    Total Assets 505.65
    Total Liabilities 505.65
    Total Equity 320.28
    Share Outstanding 9
    Price to Book Ratio 4.70
    Return on Assets (%) 4.73
    Return on Capital (%) 5.93
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 19.20
    Total Assets 489.96
    Total Liabilities 489.96
    Total Equity 301.27
    Share Outstanding 9
    Price to Book Ratio 7.52
    Return on Assets (%) 5.05
    Return on Capital (%) 6.23
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 18.85
    Total Assets 456.28
    Total Liabilities 456.28
    Total Equity 281.82
    Share Outstanding 0
    Price to Book Ratio 4.33
    Return on Assets (%) 9.48
    Return on Capital (%) 11.58
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 26.48
    Total Assets 383.73
    Total Liabilities 383.73
    Total Equity 243.48
    Share Outstanding 0
    Price to Book Ratio 4.10
    Return on Assets (%) 16.04
    Return on Capital (%) 19.12
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 24.62
    Total Assets 338.40
    Total Liabilities 338.40
    Total Equity 185.80
    Share Outstanding 0
    Price to Book Ratio 1.70
    Return on Assets (%) 7.86
    Return on Capital (%) 9.82
    Particulars MAR 2025 (Values in Cr)
    Net Income 39.67
    Cash from Operations 45.46
    Cash from Investing -12.17
    Cash from Financing -25.89
    Net change in Cash -3.36
    Free Cash Flow 60.88
    Particulars MAR 2024 (Values in Cr)
    Net Income 53.44
    Cash from Operations 31.04
    Cash from Investing -15.94
    Cash from Financing -8.77
    Net change in Cash -2.62
    Free Cash Flow 49.46
    Particulars MAR 2023 (Values in Cr)
    Net Income 72.51
    Cash from Operations 32.24
    Cash from Investing -23.96
    Cash from Financing 0.13
    Net change in Cash -7.73
    Free Cash Flow 60.99
    Particulars MAR 2022 (Values in Cr)
    Net Income 95.26
    Cash from Operations 52.46
    Cash from Investing -15.58
    Cash from Financing -17.54
    Net change in Cash 1.26
    Free Cash Flow 73.09
    Particulars MAR 2021 (Values in Cr)
    Net Income 41.33
    Cash from Operations 56.89
    Cash from Investing -15.65
    Cash from Financing -25.64
    Net change in Cash 15.67
    Free Cash Flow 74.93
    Particulars MAR 2025 (Values in Cr)
    Net Income 33.76
    Cash from Operations 45.45
    Cash from Investing -12.17
    Cash from Financing -25.89
    Net change in Cash -3.36
    Free Cash Flow 60.88
    Particulars MAR 2024 (Values in Cr)
    Net Income 34.66
    Cash from Operations 31.00
    Cash from Investing -15.95
    Cash from Financing -8.77
    Net change in Cash -2.68
    Free Cash Flow 49.41
    Particulars MAR 2023 (Values in Cr)
    Net Income 58.90
    Cash from Operations 32.22
    Cash from Investing -23.96
    Cash from Financing 0.13
    Net change in Cash -7.75
    Free Cash Flow 60.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 83.93
    Cash from Operations 52.46
    Cash from Investing -15.58
    Cash from Financing -17.54
    Net change in Cash 1.26
    Free Cash Flow 73.09
    Particulars MAR 2021 (Values in Cr)
    Net Income 32.24
    Cash from Operations 56.89
    Cash from Investing -15.65
    Cash from Financing -25.64
    Net change in Cash 15.67
    Free Cash Flow 74.93
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    THEMIS MEDICARE LTD. shareholding pattern

    Holding
    32.77%
    67.1%
    0.1%
    0.01%
    2.43%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    THEMIS MEDICARE LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    116.17 -0.67 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 116.10
    • 26 Days 111.20
    • 10 Days 115.30
    • 50 Days 106.10
    • 12 Days 114.80
    • 100 Days 101.50
    • 20 Days 112.70
    • 200 Days 108.30
    115.51 PIVOT
    First Support 113.43 First Resistance 118.12 Second Support 110.82 Second Resistance 120.20 Third Support 108.74 Third Resistance 122.81
    RSI 57.19 ADX 38.83 MACD 4.24 Williams % R -55.44 Commodity Channel Index (CCI) 57.28
    Date 2026-07-10 Week 55668.00 Same Day 29899.00 Month 99330.00
    1 Year 1.46 3 Year 1.55
    Over 1 Month
    13.39% down
    Over 1 Year
    -5.59% down
    Over 3 Months
    39.92% down
    Over 3 Years
    -7.74% down
    Over 6 Months
    22.98% down
    Over 5 Years
    8.97% down

    THEMIS MEDICARE LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.5 Final 05 Sep 2025 Equity shares
    12 Jul 2024 0.5 Final 15 Jul 2024 Equity shares
    01 Sep 2023 5.0 Final 02 Sep 2023 Equity shares
    08 Sep 2022 5.0 Final 12 Sep 2022 Equity shares
    08 Sep 2021 4.3 Final 11 Sep 2021 Equity shares
    17 Sep 2020 1.75 Final 21 Sep 2020 Equity shares
    20 Jul 2011 3.0 Final 22 Jul 2011 Equity shares
    16 Jun 2010 3.0 Final 18 Jun 2010 Equity shares
    01 Aug 2008 2.5 Final 05 Aug 2008 Equity shares
    14 Sep 2007 2.0 Final 18 Sep 2007 Equity shares
    03 Aug 2005 0.0 Final 05 Aug 2005 Equity shares
    Ex-Date Old FV NEW FV Record Date
    10 Oct 2023 10.0 1.0 10 Oct 2023
    Dividend date Dividend amount Dividend type Record date Instrument type
    04 Sep 2025 0.5 Final 05 Sep 2025 Equity shares
    12 Jul 2024 0.5 Final 15 Jul 2024 Equity shares
    01 Sep 2023 5.0 Final 02 Sep 2023 Equity shares
    08 Sep 2022 5.0 Final 12 Sep 2022 Equity shares
    08 Sep 2021 4.3 Final 11 Sep 2021 Equity shares
    17 Sep 2020 1.75 Final 21 Sep 2020 Equity shares
    20 Jul 2011 3.0 Final 22 Jul 2011 Equity shares
    16 Jun 2010 3.0 Final 18 Jun 2010 Equity shares
    01 Aug 2008 2.5 Final 05 Aug 2008 Equity shares
    14 Sep 2007 2.0 Final 18 Sep 2007 Equity shares
    03 Aug 2005 0.0 Final 05 Aug 2005 Equity shares
    Ex-Date Old FV NEW FV Record Date
    10 Oct 2023 10.0 1.0 10 Oct 2023

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Themis Medicare Ltd?

    Answer Field

    Themis Medicare Ltd share price is for NSE ₹ 116.33 & for BSE ₹ 116.40 as on Jul 13 2026 03:29 PM.

    What is the Market Cap of Themis Medicare Ltd Share?

    Answer Field

    The market cap of Themis Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 13 2026 03:29 PM.

    What is the 52 Week High and Low of Themis Medicare Ltd?

    Answer Field

    The 52 Week High and Low of Themis Medicare Ltd for NSE is ₹ 148.00 and ₹ 64.95 and for BSE is ₹ 147.99 and ₹ 65.00.

    What is 1 year return for Themis Medicare Ltd?

    Answer Field

    The 1 year returns on the stock has been -5.59%.

    What is the P/E Ratio of Themis Medicare Ltd Share?

    Answer Field

    As on Jul 13 2026 03:29 PM the price-to-earnings (PE) ratio for Themis Medicare Ltd share is -75.97.

    What is the PB ratio of Themis Medicare Ltd Share?

    Answer Field

    As on Jul 13 2026 03:29 PM, the price-to-book (PB) ratio for Themis Medicare Ltd share is 29.09.

    How to Buy Themis Medicare Ltd Share?

    Answer Field

    You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Themis Medicare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Themis Medicare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Themis Medicare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |